Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 345
Filter
Add more filters

Publication year range
1.
J Infect Chemother ; 30(7): 603-607, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38219980

ABSTRACT

BACKGROUND: Paragonimiasis is a parasitic disease primarily contracted through consumption of undercooked freshwater crustaceans or wild boar meat. Large-scale nationwide epidemiological data on paragonimiasis are lacking. In this study, we aimed to investigate the nationwide epidemiology of hospitalized patients with paragonimiasis in Japan using a comprehensive nationwide Japanese administrative database. METHODS: We evaluated the Japanese Diagnosis Procedure Combination (DPC) data of patients diagnosed with pulmonary paragonimiasis between April 1, 2012 and March 30, 2020. The patients' address and information, including age, sex, treatment (medication: praziquantel; surgery: open thoracotomy or intracranial mass extirpation), Japan coma scale, comorbidities, and length of hospital stay, were extracted. RESULTS: Of the 49.6 million hospitalized patients, data were extracted on 73 patients with paragonimiasis, of whom 36 were male and 37 were female. The mean age was 49.7 years and the mean length of stay was 12.5 days. The most frequent comorbidity was pleural effusion (31.5 %), followed by pneumothorax (13.7 %). The sites of ectopic paragonimiasis in organs other than the lung included the liver (5.5 %), skin (4.1 %), and brain (2.7 %). Geographically, most patients were from the Kyushu region (54.8 %), followed by the Kanto region (22.0 %). Fukuoka Prefecture had the highest number of patients (22.0 %) by prefecture. During the study period, an average of 9.1 patients/year were hospitalized with lung paragonimiasis in Japan. CONCLUSION: Paragonimiasis has not completely disappeared in Japan; thus, physicians should be aware of paragonimiasis in the Kyushu region, especially in the Fukuoka Prefecture.


Subject(s)
Databases, Factual , Paragonimiasis , Humans , Paragonimiasis/epidemiology , Japan/epidemiology , Male , Female , Middle Aged , Adult , Aged , Length of Stay/statistics & numerical data , Lung Diseases, Parasitic/epidemiology , Lung Diseases, Parasitic/parasitology , Lung Diseases, Parasitic/drug therapy , Young Adult , Hospitalization/statistics & numerical data , Praziquantel/therapeutic use , Adolescent , Animals , Comorbidity , East Asian People
2.
Zhonghua Jie He He Hu Xi Za Zhi ; 47(6): 547-549, 2024 Jun 12.
Article in Zh | MEDLINE | ID: mdl-38858205

ABSTRACT

Hymenolepis diminuta is a common parasite of rats and mice, but is very rare in humans with cases reported from various parts of the world. Here, we reported a case of Hymenolepis diminuta infection involving both the respiratory and digestive tracts in a 49-year-old male patient whose initial imaging and symptoms were strikingly similar to pneumonia. Since no disease-causing pathogens were found during routine examinations, we considered respiratory infection by specific pathogens before metagenomic next-generation sequencing of broncho-alveolar lavage fluid confirmed the diagnosis of Hymenolepis diminuta. After confirming the diagnosis, we retested the patient's stool repeatedly and found Hymenolepis diminuta eggs finally. To help doctors better understand this condition and avoid misdiagnosis, this article provided a summary of the clinical characteristics, diagnostic techniques, and therapeutic options for infection by Hymenolepis diminuta.


Subject(s)
Hymenolepiasis , Hymenolepis diminuta , Male , Middle Aged , Hymenolepiasis/diagnosis , Hymenolepiasis/drug therapy , Humans , Animals , Feces/parasitology , Lung Diseases, Parasitic/diagnosis , Lung Diseases, Parasitic/drug therapy , Lung Diseases, Parasitic/parasitology
3.
Exp Parasitol ; 199: 24-29, 2019 Apr.
Article in English | MEDLINE | ID: mdl-30796912

ABSTRACT

The genus Acanthamoeba, which may cause different infections in humans, occurs widely in the environment. Lung inflammation caused by these parasites induces pulmonary pathological changes such as pulmonary necrosis, peribronchial plasma cell infiltration, moderate desquamation of alveolar cells and partial destruction of bronchial epithelial cells, and presence of numerous trophozoites and cysts among inflammatory cells. The aim of this study was to assess the influence of plant extracts from Artemisia annua L. on expression of the toll-like receptors TLR2 and TLR4 in lungs of mice with acanthamoebiasis. A. annua, which belongs to the family Asteraceae, is an annual plant that grows wild in Asia. In this study, statistically significant changes of expression of TLR2 and TLR4 were demonstrated. In the lungs of infected mice after application of extract from A. annua the expression of TLRs was observed mainly in bronchial epithelial cells, pneumocytes (to a lesser extent during the outbreak of infection), and in the course of high general TLR expression. TLR4 in particular was also visible in stromal cells of lung parenchyma. In conclusion, we confirmed that a plant extract of A. annua has a modulatory effect on components of the immune system such as TLR2 and TLR4.


Subject(s)
Acanthamoeba/physiology , Amebiasis/drug therapy , Artemisia annua/chemistry , Lung Diseases, Parasitic/drug therapy , Plant Extracts/therapeutic use , Toll-Like Receptors/metabolism , Amebiasis/metabolism , Animals , DNA, Complementary/metabolism , Immunohistochemistry , Lung/parasitology , Lung/pathology , Lung Diseases, Parasitic/metabolism , Mice , Mice, Inbred BALB C , Plant Extracts/pharmacology , RNA, Messenger/metabolism , RNA, Protozoan/genetics , RNA, Protozoan/isolation & purification , Real-Time Polymerase Chain Reaction , Reverse Transcriptase Polymerase Chain Reaction , Reverse Transcription , Toll-Like Receptor 2/drug effects , Toll-Like Receptor 2/genetics , Toll-Like Receptor 2/metabolism , Toll-Like Receptor 4/drug effects , Toll-Like Receptor 4/genetics , Toll-Like Receptor 4/metabolism , Toll-Like Receptors/drug effects , Toll-Like Receptors/genetics
5.
BMC Vet Res ; 13(1): 148, 2017 May 30.
Article in English | MEDLINE | ID: mdl-28558828

ABSTRACT

BACKGROUND: The anthelmintic efficacy of the 0.5% w/v topical formulation of eprinomectin (EPN), EPRINEX® Pour-on (Merial) when administered at 1 mg/kg body weight was evaluated in sheep in two dose confirmation laboratory studies and one multicenter field study. In addition, the pharmacokinetics of EPN when administered at that dosage to adult sheep was determined. RESULTS: In the two dose confirmation studies, which included 10 sheep each, sheep treated with topical EPN had significantly (p < 0.05) fewer of the following nematodes than the untreated sheep with overall reduction of nematode counts by >99%: adult Dictyocaulus filaria, Haemonchus contortus, Teladorsagia circumcincta(pinnata/trifurcata), Trichostrongylus axei, T. colubriformis, T. vitrinus, Cooperia curticei, Nematodirus battus, Strongyloides papillosus, Chabertia ovina and Oesophagostomum venulosum, and inhibited fourth-stage Teladorsagia larvae. A total of 196 sheep harboring naturally acquired gastrointestinal nematode infections were included in the field efficacy study at two sites each in Germany (48 Merino x Ile de France lambs, 52 adult Merino females) and in Italy (adult male and female Bagnolese, Lacaune, Lacaune x Bagnolese, Bagnolese x Sarda sheep; 48 animals per site). Animals were blocked on pre-treatment body weight and within each block, one animal was randomly assigned to the control (untreated) group and three animals were randomly assigned to be treated with topical EPN. Examination of feces 14 days after treatment demonstrated that, relative to the controls, topical EPN-treated sheep had significantly (p < 0.0001) lower strongylid egg counts. Reduction was ≥97% at each site and 98.6% across all sites. Pharmacokinetics of EPN following single treatment with topical EPN were determined in eight ~4.5 year old female Merino cross sheep based on the analysis of plasma samples which were collected from two hours to 21 days following treatment. The main pharmacokinetic parameters were: Cmax 6.20 ± 1.71 ng/mL, AUClast 48.8 ± 19.2 day*ng/mL, Tmax 3.13 ± 2.99 days and T1/2 6.40 ± 2.95 days. No treatment-related health problems or adverse drug events were observed in any study. CONCLUSION: These studies demonstrated 0.5% w/v EPN administered topically at 1 mg/kg body weight to be highly efficacious against a broad range of ovine gastrointestinal nematodes and D. filaria lungworms and well tolerated by sheep of different ages, breeds, gender and physiological status.


Subject(s)
Antinematodal Agents/therapeutic use , Gastrointestinal Diseases/veterinary , Ivermectin/analogs & derivatives , Lung Diseases, Parasitic/veterinary , Nematode Infections/veterinary , Sheep Diseases/parasitology , Animals , Antinematodal Agents/pharmacokinetics , Female , Gastrointestinal Diseases/parasitology , Helminthiasis, Animal/drug therapy , Ivermectin/pharmacokinetics , Ivermectin/therapeutic use , Lung Diseases, Parasitic/drug therapy , Male , Nematode Infections/drug therapy , Sheep , Sheep Diseases/drug therapy
6.
Parasitol Res ; 116(12): 3429-3435, 2017 Dec.
Article in English | MEDLINE | ID: mdl-29034414

ABSTRACT

The present study investigated for the first time the occurrence of pulmonary and intestinal parasites of cats in Cyprus. Cats from five districts of Cyprus (Lefkosia, Lemesos, Larnaka, Pafos and Ammochostos) were examined by classical parasitological methods and the identity of lungworm larvae, whenever present, was confirmed by PCR-coupled sequencing. A total of 185 cats, 48 living exclusively indoors and 137 with outdoor access, were included in the study. Parasites were found in 66 (35.7%) of the examined cats, i.e. Toxocara cati (12%), Cystoisospora rivolta (12%), Joyeuxiella/Diplopylidium spp. (7%), Giardia spp. (6.5%), Troglostrongylus brevior (5%), Cystoisospora felis (2.5%), Aelurostrongylus abstrusus (2%), Taenia spp. (0.5%) and Dipylidium caninum (0.5%). Mixed infections were recorded in 18 cats. Cats that lived exclusively indoors or had received an antiparasitic treatment in the last 6 months were less likely to be infected (p < 0.05). Moreover, cats younger than 1 year old were more likely to shed first-stage larvae of T. brevior (p = 0.04). The present study shows that cats in Cyprus are infected at a high percentage by a variety of parasites that potentially affect their health and also, in some cases (i.e. T. cati, D. caninum, Giardia spp.), may have an impact on human health. Moreover, it was revealed that T. brevior, a lungworm of emerging significance, is present on the island, rendering Cyprus the easternmost distribution border of this parasite in Europe to date.


Subject(s)
Cat Diseases/epidemiology , Intestinal Diseases, Parasitic/epidemiology , Intestinal Diseases, Parasitic/veterinary , Lung Diseases, Parasitic/epidemiology , Lung Diseases, Parasitic/veterinary , Strongylida Infections/epidemiology , Animals , Antiparasitic Agents/therapeutic use , Cat Diseases/drug therapy , Cat Diseases/parasitology , Cats , Coinfection/parasitology , Cyprus/epidemiology , Feces/parasitology , Intestinal Diseases, Parasitic/drug therapy , Larva , Lung Diseases, Parasitic/drug therapy , Metastrongyloidea/genetics , Polymerase Chain Reaction , Strongylida Infections/parasitology , Strongylida Infections/veterinary
7.
Infection ; 42(3): 575-8, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24452526

ABSTRACT

Toxocariasis is a parasitic disease caused by Toxocara canis or T. cati. We report a patient with toxocariasis who presented with dyspnea, high-grade eosinophilia, and bilateral pulmonary nodules. To further characterize the pulmonary manifestations of toxocariasis, we have reviewed 11 previously published pulmonary toxocariasis cases. The most common pulmonary symptoms in our review were cough and dyspnea, and the most common finding on chest imaging was bilateral pulmonary nodules. Risk factors for Toxocara infection primarily included exposure to dogs. Most patients received albendazole and responded well. A high index of suspicion is needed to diagnose this otherwise preventable parasitic disease.


Subject(s)
Lung Diseases, Parasitic/diagnosis , Lung Diseases, Parasitic/pathology , Toxocara/isolation & purification , Toxocariasis/diagnosis , Toxocariasis/pathology , Aged , Albendazole/therapeutic use , Animals , Anthelmintics/therapeutic use , Female , Humans , Lung Diseases, Parasitic/drug therapy , Lung Diseases, Parasitic/parasitology , Toxocariasis/drug therapy , Toxocariasis/parasitology
8.
Mem Inst Oswaldo Cruz ; 109(7): 849-55, 2014 Nov.
Article in English | MEDLINE | ID: mdl-25410987

ABSTRACT

A review of national and international publications on paragonimiasis in Ecuador, epidemiological records from the Ministry of Public Health and unpublished research data was conducted to summarise the current status of the parasite/disease. The purpose of the review is to educate physicians, policy-makers and health providers on the status of the disease and to stimulate scientific investigators to conduct further research. Paragonimiasis was first diagnosed in Ecuador 94 years ago and it is endemic to both tropical and subtropical regions in 19 of 24 provinces in the Pacific Coast and Amazon regions. Paragonimus mexicanus is the only known species in the country, with the mollusc Aroapyrgus colombiensis and the crabs Moreirocarcinus emarginatus, Hypolobocera chilensis and Hypolobocera aequatorialis being the primary and secondary intermediate hosts, respectively. Recent studies found P. mexicanus metacercariae in Trichodactylus faxoni crabs of the northern Amazon. Chronic pulmonary paragonimiasis is commonly misdiagnosed and treated as tuberculosis and although studies have demonstrated the efficacy of praziquantel and triclabendazole for the treatment of human infections, neither drug is available in Ecuador. Official data recorded from 1978-2007 indicate an annual incidence of 85.5 cases throughout the 19 provinces, with an estimated 17.2% of the population at risk of infection. There are no current data on the incidence/prevalence of infection, nor is there a national control programme.


Subject(s)
Lung Diseases, Parasitic/epidemiology , Metacercariae/isolation & purification , Paragonimiasis/epidemiology , Paragonimus/classification , Animals , Anthelmintics/therapeutic use , Astacoidea/parasitology , Brachyura/parasitology , Chronic Disease , Ecuador/epidemiology , Humans , Lung Diseases, Parasitic/diagnosis , Lung Diseases, Parasitic/drug therapy , Neglected Diseases/epidemiology , Paragonimiasis/diagnosis , Paragonimiasis/drug therapy
9.
J Int Med Res ; 52(2): 3000605241232917, 2024 Feb.
Article in English | MEDLINE | ID: mdl-38410853

ABSTRACT

In this case report, we address the diagnostic challenges and clinical implications of severe infection with Lophomonas blattarum in a patient initially suspected of experiencing long COVID symptoms. We describe the patient's medical history, initial symptoms, diagnostic tests, and treatment. A female patient with diabetes in her early 60s presented with severe shortness of breath and was initially diagnosed with diabetic ketoacidosis (DKA). After resolution of her DKA symptoms, persistent respiratory issues led to a COVID-19 test, which was negative. A chest computed tomography scan revealed abnormalities, prompting bronchoscopy and bronchoalveolar lavage fluid analysis, which confirmed the presence of L. blattarum. Notably, the protozoan remained mobile and viable even after a 4-day transport at ambient temperature. This case emphasizes the importance of considering alternative diagnoses and improving awareness about L. blattarum infection in patients with respiratory symptoms, for timely and accurate management.


Subject(s)
COVID-19 , Diabetes Mellitus , Diabetic Ketoacidosis , Lung Diseases, Parasitic , Protozoan Infections , Humans , Female , Protozoan Infections/complications , Protozoan Infections/diagnosis , Lung Diseases, Parasitic/diagnosis , Lung Diseases, Parasitic/drug therapy , Lung Diseases, Parasitic/etiology , Iran , Post-Acute COVID-19 Syndrome , COVID-19/complications , Diabetic Ketoacidosis/complications
10.
Acta Anaesthesiol Scand ; 57(7): 944-5, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23679043
11.
Emerg Infect Dis ; 18(8): 1263-7, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22840191

ABSTRACT

Paragonimiasis is an infection caused by lung flukes of the genus Paragonimus. In Asia, P. westermani infections are relatively common because of dietary practices. However, in North America, cases of paragonimiasis, which are caused by P. kellicotti flukes, are rare. Only 7 autochthonous cases of paragonimiasis were reported during 1968-2008. In 2009, we reported 3 new case-patients with paragonimiasis who had been seen at our medical center over an 18-month period. Six additional case-patients were identified in St. Louis, Missouri, USA, and treated at Washington University-affiliated health centers in 2009-2010. We report detailed descriptions of these case-patients, which includes unusual clinical manifestations. We also describe public health interventions that were undertaken to inform the general public and physicians about the disease and its mode of transmission.


Subject(s)
Communicable Diseases, Emerging/epidemiology , Lung Diseases, Parasitic/epidemiology , Paragonimiasis/epidemiology , Paragonimus , Adult , Animals , Anthelmintics/therapeutic use , Astacoidea/parasitology , Child , Communicable Diseases, Emerging/diagnosis , Communicable Diseases, Emerging/drug therapy , Communicable Diseases, Emerging/parasitology , Female , Food Contamination , Humans , Lung Diseases, Parasitic/diagnosis , Lung Diseases, Parasitic/drug therapy , Lung Diseases, Parasitic/parasitology , Male , Missouri/epidemiology , Paragonimiasis/diagnosis , Paragonimiasis/drug therapy , Paragonimiasis/parasitology , Paragonimus/classification , Paragonimus/isolation & purification , Praziquantel/therapeutic use , Shellfish/parasitology , Young Adult
12.
J Med Liban ; 60(2): 122-4, 2012.
Article in English | MEDLINE | ID: mdl-22919872

ABSTRACT

Pleuropulmonary amebiasis is the 2nd most common extraintestinal site of amebiasis after liver abscess. We describe a man with pleuropulmonary amebiasis presenting with pulmonary consolidation and pleural effusion. In patients with pneumonia coming from endemic countries such as Lebanon, pleuropulmonary amebiasis should be considered in the setting of chocolate-colored sputum, negative respiratory cultures, and failure of antibacterial therapy.


Subject(s)
Amebiasis/diagnosis , Lung Diseases, Parasitic/diagnosis , Pleural Diseases/parasitology , Aged, 80 and over , Amebiasis/drug therapy , Antiprotozoal Agents/therapeutic use , Humans , Immunocompetence , Lung Diseases, Parasitic/drug therapy , Male , Metronidazole/therapeutic use , Pleural Diseases/diagnosis , Pleural Diseases/drug therapy , Pleural Effusion/diagnostic imaging , Pleural Effusion/etiology , Tomography, X-Ray Computed
13.
Eur Respir Rev ; 31(166)2022 Dec 31.
Article in English | MEDLINE | ID: mdl-36450370

ABSTRACT

Parasitic lung diseases are caused by a number of parasites as a result of transient passage in the lung or as a result of an immunologic reaction. The clinical presentation may be in the form of focal or cystic lesions, pleural effusion or diffuse pulmonary infiltrates. With increasing globalisation, it is important to consider parasitic infections in the differential diagnosis of lung diseases. This is particularly important since early identification and prompt therapy result in full cure of these conditions. In this review, we summarise the most common parasitic lung diseases.


Subject(s)
Lung Diseases, Parasitic , Pleural Effusion , Humans , Lung Diseases, Parasitic/diagnosis , Lung Diseases, Parasitic/drug therapy , Diagnosis, Differential , Thorax
14.
Thorax ; 66(6): 528-36, 2011 Jun.
Article in English | MEDLINE | ID: mdl-20880867

ABSTRACT

Parasitic infections of the lung occur worldwide among both immunocompetent and immunocompromised patients and may affect the respiratory system in a variety of ways. This review provides an update on the presenting symptoms, signs, investigation and management of diseases affecting the lung caused by protozoa, nematodes and trematodes. The clinical presentations and radiographic findings of several of these diseases may mimic tuberculosis and malignancy. It is important to consider parasitic infections in the differential diagnosis of such lung diseases. If identified early, most parasitic diseases that affect the lung are curable with medical or surgical treatments.


Subject(s)
Lung Diseases, Parasitic/diagnostic imaging , Amebiasis/diagnostic imaging , Antiparasitic Agents/therapeutic use , Diagnosis, Differential , Echinococcosis, Pulmonary/diagnostic imaging , Humans , Lung Diseases, Parasitic/drug therapy , Lung Neoplasms/diagnosis , Pulmonary Medicine , Schistosomiasis/diagnostic imaging , Strongyloidiasis/diagnostic imaging , Tomography, X-Ray Computed , Tuberculosis, Pulmonary/diagnosis
15.
PLoS Pathog ; 5(4): e1000393, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19381262

ABSTRACT

Retnla (Resistin-like molecule alpha/FIZZ1) is induced during Th2 cytokine immune responses. However, the role of Retnla in Th2-type immunity is unknown. Here, using Retnla(-/-) mice and three distinct helminth models, we show that Retnla functions as a negative regulator of Th2 responses. Pulmonary granuloma formation induced by the eggs of the helminth parasite Schistosoma mansoni is dependent on IL-4 and IL-13 and associated with marked increases in Retnla expression. We found that both primary and secondary pulmonary granuloma formation were exacerbated in the absence of Retlna. The number of granuloma-associated eosinophils and serum IgE titers were also enhanced. Moreover, when chronically infected with S. mansoni cercariae, Retnla(-/-) mice displayed significant increases in granulomatous inflammation in the liver and the development of fibrosis and progression to hepatosplenic disease was markedly augmented. Finally, Retnla(-/-) mice infected with the gastrointestinal (GI) parasite Nippostrongylus brasiliensis had intensified lung pathology to migrating larvae, reduced fecundity, and accelerated expulsion of adult worms from the intestine, suggesting Th2 immunity was enhanced. When their immune responses were compared, helminth infected Retnla(-/-) mice developed stronger Th2 responses, which could be reversed by exogenous rRelmalpha treatment. Studies with several cytokine knockout mice showed that expression of Retnla was dependent on IL-4 and IL-13 and inhibited by IFN-gamma, while tissue localization and cell isolation experiments indicated that eosinophils and epithelial cells were the primary producers of Retnla in the liver and lung, respectively. Thus, the Th2-inducible gene Retnla suppresses resistance to GI nematode infection, pulmonary granulomatous inflammation, and fibrosis by negatively regulating Th2-dependent responses.


Subject(s)
Intercellular Signaling Peptides and Proteins/physiology , Schistosomiasis mansoni/immunology , Strongylida Infections/immunology , Th2 Cells/immunology , Animals , Eosinophils/metabolism , Granuloma/metabolism , Immunity, Innate , Intercellular Signaling Peptides and Proteins/therapeutic use , Interferon-gamma/physiology , Interleukin-13/physiology , Interleukin-4/physiology , Lung Diseases, Parasitic/drug therapy , Lung Diseases, Parasitic/immunology , Mice , Mice, Inbred C57BL , Nippostrongylus/immunology , Pulmonary Fibrosis/parasitology , Schistosoma mansoni/immunology , Schistosomiasis mansoni/drug therapy , Strongylida Infections/drug therapy
16.
Korean J Parasitol ; 49(4): 409-12, 2011 Dec.
Article in English | MEDLINE | ID: mdl-22355209

ABSTRACT

In Korea, many people enjoy eating raw or underkooked freshwater crayfish and crabs which unfortunately may cause paragonimiasis. Here, we describe a case of pulmonary and abdominal paragonimiasis in a 9-year-old girl, who presented with a 1-month history of abdominal pain, especially in the right flank and the right inguinal area, with anorexia. A chest radiograph revealed pleural effusion in both lungs, and her abdominal sonography indicated an inflammatory lesion in the right psoas muscle. Peripheral blood analysis of the patient showed hypereosinophilia (66.0%) and an elevated total serum IgE level (>2,500 IU/ml). The pleural effusion tested by ELISA were also positive for antibodies against paragonimiasis. Her dietary history stated that she had ingested raw freshwater crab, 4 months previously. The diagnosis was pulmonary paragonimiasis accompanied by abdominal muscle involvement. She was improved after 5 cycles of praziquantel treatment and 2 times of pleural effusion drainage. In conclusion, herein, we report a case of pulmonary and abdominal paragonimiasis in a girl who presented with abdominal pain and tenderness in the inguinal area.


Subject(s)
Abdominal Muscles/parasitology , Brachyura/parasitology , Lung Diseases, Parasitic/diagnosis , Paragonimiasis/diagnosis , Shellfish/parasitology , Abdominal Muscles/diagnostic imaging , Abdominal Muscles/pathology , Animals , Anthelmintics/therapeutic use , Child , Drainage , Female , Humans , Lung/parasitology , Lung/pathology , Lung Diseases, Parasitic/diagnostic imaging , Lung Diseases, Parasitic/drug therapy , Paragonimiasis/diagnostic imaging , Paragonimiasis/drug therapy , Paragonimus/isolation & purification , Pleural Effusion/parasitology , Pleural Effusion/therapy , Praziquantel/therapeutic use , Radiography , Republic of Korea , Treatment Outcome , Ultrasonography
17.
J La State Med Soc ; 163(5): 261-6, 2011.
Article in English | MEDLINE | ID: mdl-22272548

ABSTRACT

Paragonimiasis is a parasitic infection of the lungs caused by zoonotic lung flukes of the genus Paragonimus. Most cases are reported from Asia and caused by P. westermani following consumption of raw crustaceans. With the exception of imported cases, human paragonimiasis was rarely described prior to 1984 in the United States (US), which has only one indigenous lung fluke species, P. kellicotti. Between 1984 and 2010, 15 cases of P. kellicotti paragonimiasis were reported in the United States. This study will analyze all US cases and compare an earlier series of six cases reported during the period 1984-2005 with a recently reported cluster of nine cases from Missouri during the period 2006-2010 in order to determine any significant behavioral and/ or recreational risk factors for paragonimiasis and to recommend early diagnostic, treatment and preventive strategies. Significant behavioral and recreational risk factors included eating raw crayfish while on canoeing trips on local rivers (p = 0.002), eating raw crayfish while on canoeing trips in Missouri (p = 0.002), and eating raw crayfish while intoxicated (p = 0.007). The male:female case ratio was 9.3:1.0 and more than 80% of cases presented with fever, cough, pleural effusions and peripheral eosinophilia. One patient developed cerebral paragonimiasis, and one patient died of pneumonic sepsis. Clinicians should inquire about consumption of raw or undercooked crayfish in all patients with unexplained fever, cough, eosinophilia and pleural effusions returning from camping or canoeing adventures in P. kellicotti-endemic areas of the Mississippi River Drainage Basin; institute diagnostic evaluation by specific parasitological and serological methods and treat all cases as soon as possible to avoid the pulmonary and cerebral complications of paragonimiasis.


Subject(s)
Astacoidea/parasitology , Lung Diseases, Parasitic/epidemiology , Paragonimiasis/epidemiology , Rivers , Adolescent , Adult , Aged , Analysis of Variance , Animals , Anthelmintics/therapeutic use , Child , Cooking , Diagnosis, Differential , Female , Food Contamination , Food Parasitology , Humans , Lung Diseases, Parasitic/diagnosis , Lung Diseases, Parasitic/drug therapy , Male , Middle Aged , Missouri/epidemiology , Paragonimiasis/diagnosis , Paragonimiasis/drug therapy , Paragonimus westermani , Praziquantel/therapeutic use , United States/epidemiology
18.
Harefuah ; 150(12): 899-901, 936, 2011 Dec.
Article in Hebrew | MEDLINE | ID: mdl-22352281

ABSTRACT

Echinococcus granulosus is a tapeworm that causes zoonotic infection (echinococcosis or hydatid disease), transferred to humans by ingestion of contaminated food with the parasite's eggs. Echinococcosis is endemic in southern Israel, especially in the Bedouin population. Humans, the intermediate hosts of the worm, develop cystic (larval) disease mainly of the liver or the lungs over long durations. Diagnosis requires a high index of suspicion, typical radiographic findings and specific serology test, which has low sensitivity in extra-hepatic cases. We report a 12 year old patient with fever, cough and chest pain, who was considered to have bacterial pneumonia with typical radiographic findings, and was treated with ceftriaxone and azithromycin. The patient did not recover as expected within a few days, and further investigation revealed evidence of hydatid cystic disease of her left lung, despite having negative serology for echinococcus. The patient fully recovered after surgical and albendazole treatment. We believe that hydatid disease should be suspected when a patient from an endemic area presents with fever and cough, supposedly representing as community acquired pneumonia, unresponsive to empiric antibiotic treatment. The radiographic findings should be carefully examined for typical findings, and negative serology for echinococcus does not rule out the diagnosis of hydatid cystic disease.


Subject(s)
Echinococcosis/diagnosis , Lung Diseases, Parasitic/diagnosis , Pneumonia/diagnosis , Albendazole/therapeutic use , Anticestodal Agents/therapeutic use , Child , Echinococcosis/drug therapy , Echinococcosis/surgery , Female , Humans , Lung Diseases, Parasitic/drug therapy , Lung Diseases, Parasitic/surgery
19.
Nihon Kokyuki Gakkai Zasshi ; 49(5): 399-403, 2011 May.
Article in Japanese | MEDLINE | ID: mdl-21688651

ABSTRACT

A 36-year-old man who often ate raw chicken meat had abnormal chest radiograph findings on a health check-up in July 2009, and visited our department. A chest computed tomographic scan revealed 6 nodular shadows in both lungs, and a hematologic examination revealed eosinophilia and elevation of IgE. Because of his history of eating raw chicken meat, antiparasite antibody testing was performed which revealed antibodies to Toxocara canis, leading to the diagnosis of pulmonary toxocariasis due to Toxocara canis. Although treatment with albendazole was performed, it was discontinued because of hepatic impairment. However, hematological examination showed that his eosinophil count and IgE increased again, and chest image findings were exacerbated. Therefore, ivermectin, reported as effective in cases outside Japan, was administered, resulting in decreased peripheral eosinophils, normalized IgE level, and disappearance of the shadows on chest images. In Japan, no cases of pulmonary toxocariasis responding well to ivermectin have previously been reported. Administration of ivermectin should be considered when albendazol cannot be used due to hepatic impairment or related problems.


Subject(s)
Antiparasitic Agents/therapeutic use , Ivermectin/therapeutic use , Lung Diseases, Parasitic/drug therapy , Toxocara canis , Toxocariasis/drug therapy , Adult , Animals , Humans , Male
20.
Niger J Clin Pract ; 14(4): 501-3, 2011.
Article in English | MEDLINE | ID: mdl-22248961

ABSTRACT

We report a case of human pentastomiasis in a 70-year-old retired long-distance driver/farmer whose diagnosis was made incidentally while being investigated for a 1-month history of cough and abdominal pain. The chest X-ray revealed multiple comma-shaped and rounded opacities in keeping with Armillifer infection, most likely Armillifer armillatus. The patient made an uneventful recovery after a 10-day course of mebendazole (an antihelminthic) tablet and ciprofloxacin (antibiotic) capsules and was discharged home. He is presently being followed up. This is the first case we have seen in our medical unit thus we are reporting it.


Subject(s)
Liver Diseases, Parasitic/diagnostic imaging , Lung Diseases, Parasitic/diagnostic imaging , Pentastomida , Abdominal Pain/etiology , Aged , Animals , Anti-Infective Agents/therapeutic use , Antinematodal Agents/therapeutic use , Ciprofloxacin/therapeutic use , Cough/etiology , Humans , Incidental Findings , Liver Diseases, Parasitic/drug therapy , Liver Diseases, Parasitic/parasitology , Lung Diseases, Parasitic/drug therapy , Lung Diseases, Parasitic/parasitology , Male , Mebendazole/therapeutic use , Radiography , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL